Noah D. Peyser

2.2k total citations · 1 hit paper
22 papers, 738 citations indexed

About

Noah D. Peyser is a scholar working on Clinical Psychology, Oncology and Infectious Diseases. According to data from OpenAlex, Noah D. Peyser has authored 22 papers receiving a total of 738 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Clinical Psychology, 8 papers in Oncology and 6 papers in Infectious Diseases. Recurrent topics in Noah D. Peyser's work include COVID-19 and Mental Health (8 papers), Lung Cancer Treatments and Mutations (5 papers) and COVID-19 Clinical Research Studies (4 papers). Noah D. Peyser is often cited by papers focused on COVID-19 and Mental Health (8 papers), Lung Cancer Treatments and Mutations (5 papers) and COVID-19 Clinical Research Studies (4 papers). Noah D. Peyser collaborates with scholars based in United States, Hong Kong and China. Noah D. Peyser's co-authors include Jennifer R. Grandis, Gregory M. Marcus, Jeffrey E. Olgin, Mark J. Pletcher, Alexis L. Beatty, Xochitl Butcher, Feng Lin, Jennifer Cocohoba, Hua Li and Vivian Wai Yan Lui and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Cancer Research.

In The Last Decade

Noah D. Peyser

22 papers receiving 731 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Analysis of COVID-19 Vaccine Type and Adverse Effects Following Vaccination

2021 243 citations Alexis L. Beatty, Noah D. Peyser et al. JAMA Network Open profile →

Peers

Countries citing papers authored by Noah D. Peyser

Since Specialization

Citations

This map shows the geographic impact of Noah D. Peyser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noah D. Peyser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noah D. Peyser more than expected).

Fields of papers citing papers by Noah D. Peyser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Noah D. Peyser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noah D. Peyser. The network helps show where Noah D. Peyser may publish in the future.

Co-authorship network of co-authors of Noah D. Peyser

This figure shows the co-authorship network connecting the top 25 collaborators of Noah D. Peyser. A scholar is included among the top collaborators of Noah D. Peyser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Noah D. Peyser. Noah D. Peyser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Factors associated with anxiety during the first two years of the COVID-19 pandemic in the United States: An analysis of the COVID-19 Citizen Science study 2024 ·PLoS ONE ·Aaron E. Cozen, Thomas W. Carton, Rita Hamad, John Kornak, Madelaine Faulkner Modrow, Noah D. Peyser, (unknown), (unknown), (unknown), Emily C. O’Brien, Djeneba Audrey Djibo, Cheryl N. McMahill‐Walraven, Carmen R. Isasi, Alexis L. Beatty, Jeffrey E. Olgin, Gregory M. Marcus, Mark J. Pletcher	6
2	Association of nirmatrelvir for acute SARS‐CoV‐2 infection with subsequent Long COVID symptoms in an observational cohort study 2024 ·Journal of Medical Virology ·Matthew S. Durstenfeld, Michael J. Peluso, Feng Lin, Noah D. Peyser, Carmen R. Isasi, Thomas W. Carton, Timothy J. Henrich, Steven G. Deeks, Jeffrey E. Olgin, Mark J. Pletcher, Alexis L. Beatty, Gregory M. Marcus, Priscilla Y. Hsue	28
3	Factors Associated With Long COVID Symptoms in an Online Cohort Study 2023 ·Open Forum Infectious Diseases ·Matthew S. Durstenfeld, Michael J. Peluso, Noah D. Peyser, (unknown), Sara J. Knight, (unknown), (unknown), Heather Kitzman, Emily C. O’Brien, Natasha Williams, Carmen R. Isasi, John Kornak, Thomas W. Carton, Jeffrey E. Olgin, Mark J. Pletcher, Gregory M. Marcus, Alexis L. Beatty	52
4	Associations between tobacco and cannabis use and anxiety and depression among adults in the United States: Findings from the COVID-19 citizen science study 2023 ·PLoS ONE ·Nhung Nguyen, Noah D. Peyser, Jeffrey E. Olgin, Mark J. Pletcher, Alexis L. Beatty, Madelaine Faulkner Modrow, Thomas W. Carton, (unknown), Djeneba Audrey Djibo, Pamela M. Ling, Gregory M. Marcus	16
5	Digital platforms for clinical trials: The Eureka experience 2022 ·Contemporary Clinical Trials ·Noah D. Peyser, Gregory M. Marcus, Alexis L. Beatty, Jeffrey E. Olgin, Mark J. Pletcher	14
6	Characteristics and Behaviors Associated with Prevalent SARS-CoV-2 Infection 2021 ·International Journal of General Medicine ·(unknown), Eric Vittinghoff, Gregory Nah, Noah D. Peyser, Mark J. Pletcher, Jeffrey E. Olgin, Gregory M. Marcus	7
7	Analysis of COVID-19 Vaccine Type and Adverse Effects Following Vaccination breakdown → 2021 ·JAMA Network Open ·Alexis L. Beatty, Noah D. Peyser, Xochitl Butcher, Jennifer Cocohoba, Feng Lin, Jeffrey E. Olgin, Mark J. Pletcher, Gregory M. Marcus	243
8	Predictors of incident viral symptoms ascertained in the era of COVID-19 2021 ·PLoS ONE ·Gregory M. Marcus, Jeffrey E. Olgin, Noah D. Peyser, Eric Vittinghoff, Vivian Yang, Sean Joyce, Robert Avram, Geoffrey H. Tison, (unknown), Xochitl Butcher, (unknown), Mark J. Pletcher	5
9	Predictors of incident SARS-CoV-2 infections in an international prospective cohort study 2021 ·BMJ Open ·Anthony Lin, Eric Vittinghoff, Jeffrey E. Olgin, Noah D. Peyser, (unknown), Sean Joyce, Vivian Yang, (unknown), Robert Avram, Gregory Nah, Geoffrey H. Tison, Alexis L. Beatty, Ryan Runge, (unknown), Xochitl Butcher, (unknown), (unknown), Mark J. Pletcher, Gregory M. Marcus	6
10	The COVID-19 Citizen Science Study: Protocol for a Longitudinal Digital Health Cohort Study 2021 ·JMIR Research Protocols ·Alexis L. Beatty, Noah D. Peyser, Xochitl Butcher, Thomas W. Carton, Jeffrey E. Olgin, Mark J. Pletcher, Gregory M. Marcus	18
11	STAT3 as a Chemoprevention Target in Carcinogen-Induced Head and Neck Squamous Cell Carcinoma 2016 ·Cancer Prevention Research ·Noah D. Peyser, Lin Wang, Yan Zeng, Marie Acquafondata, Maria L. Freilino, Hua Li, Malabika Sen, William E. Gooding, Masanobu Satake, Zhenghe Wang, Daniel E. Johnson, Jennifer R. Grandis	11
12	Human Papillomavirus Regulates HER3 Expression in Head and Neck Cancer: Implications for Targeted HER3 Therapy in HPV+ Patients 2016 ·Clinical Cancer Research ·Toni M. Brand, Stefan Hartmann, Neil E. Bhola, Noah D. Peyser, Hua Li, Yan Zeng, (unknown), Max V. Ranall, Sourav Bandyopadhyay, Umamaheswar Duvvuri, Theresa LaVallee, Richard C. Jordan, Daniel E. Johnson, Jennifer R. Grandis	44
13	Genomic and Transcriptomic Alterations Associated with STAT3 Activation in Head and Neck Cancer 2016 ·PLoS ONE ·Noah D. Peyser, Kelsey Pendleton, William E. Gooding, Vivian Wai Yan Lui, Daniel E. Johnson, Jennifer R. Grandis	6
14	Loss-of-Function PTPRD Mutations Lead to Increased STAT3 Activation and Sensitivity to STAT3 Inhibition in Head and Neck Cancer 2015 ·PLoS ONE ·Noah D. Peyser, Yu Du, Hua Li, Vivian Wai Yan Lui, Xiao Xiao, Timothy A. Chan, Jennifer R. Grandis	47
15	Frequent promoter hypermethylation of PTPRT increases STAT3 activation and sensitivity to STAT3 inhibition in head and neck cancer 2015 ·Oncogene ·Noah D. Peyser, Maria L. Freilino, Lin Wang, Yan Zeng, (unknown), (unknown), Jennifer R. Grandis	44
16	Genomic Analysis of Head and Neck Squamous Cell Carcinoma Cell Lines and Human Tumors: A Rational Approach to Preclinical Model Selection 2014 ·Molecular Cancer Research ·Hua Li, (unknown), William E. Gooding, Levi A. Garraway, Vivian Wai Yan Lui, Noah D. Peyser, Jennifer R. Grandis	91
17	Phosphorylation of Ezrin-Radixin-Moesin-binding Phosphoprotein 50 (EBP50) by Akt Promotes Stability and Mitogenic Function of S-phase Kinase-associated Protein-2 (Skp2) 2014 ·Journal of Biological Chemistry ·Gyun Jee Song, Kristen Leslie, Stacey Barrick, Tatyana Mamonova, Jeremy Fitzpatrick, Kenneth W. Drombosky, Noah D. Peyser, Bin Wang, Maria Pellegrini, Philip M. Bauer, Peter A. Friedman, Dale F. Mierke, Alessandro Bisello	19
18	Critical analysis of the potential for targeting STAT3 in human malignancy 2013 ·OncoTargets and Therapy ·Jennifer R. Grandis, Noah D. Peyser	21
19	Integration of molecular targeted therapy with radiation in head and neck cancer 2013 ·Pharmacology & Therapeutics ·Yu Du, Noah D. Peyser, Jennifer R. Grandis	44
20	Abstract 2011: The PI3K pathway is the most frequently mutated mitogenic pathway in HNSCC. 2013 ·Cancer Research ·Matthew L. Hedberg, Vivian Wai Yan Lui, Hua Li, Bhavana S. Vangara, Kelsey Pendleton, Yan Zeng, Breean R. Gilbert, Maria L. Freilino, Sam Sauerwein, Noah D. Peyser, Brenda Diergaarde, Peter S. Hammerman, Levi A. Garraway, Gordon B. Mills, Jennifer R. Grandis	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Swati Goel Breakdown of academic impact, for papers by Chaofan Li Breakdown of academic impact, for papers by Rana Saber Breakdown of academic impact, for papers by Yaqiong Jin Breakdown of academic impact, for papers by Liangshun You Breakdown of academic impact, for papers by Mounica Vallurupalli Breakdown of academic impact, for papers by Jimmy Yu‐Wai Chan Breakdown of academic impact, for papers by Jillian H. Hurst